A Phase 2, Multi-Center, Randomized, Double-Blind, Vehicle-Controlled Study to Evaluate the Safety and Efficacy of TSN2898 Topical Gel for the Treatment of Acne Vulgaris

Trial Profile

A Phase 2, Multi-Center, Randomized, Double-Blind, Vehicle-Controlled Study to Evaluate the Safety and Efficacy of TSN2898 Topical Gel for the Treatment of Acne Vulgaris

Withdrawn prior to enrolment
Phase of Trial: Phase II

Latest Information Update: 28 Apr 2017

At a glance

  • Drugs TSN 2898 (Primary)
  • Indications Acne vulgaris
  • Focus Adverse reactions
  • Sponsors Thesan Pharmaceuticals
  • Most Recent Events

    • 24 Apr 2017 Status changed from not yet recruiting to withdrawn prior to enrolment.
    • 05 Jul 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top